{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:43Z","timestamp":1787028403263,"version":"build-2736575974"},"reference-count":91,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T00:00:00Z","timestamp":1510963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Accumulating evidence demonstrates that vascular oxidative stress is a critical feature of atherosclerotic process, potentially triggered by several infectious agents that are considered as risk co-factors for the atherosclerotic cardiovascular diseases (CVDs). C. pneumoniae has been shown to upregulate multiple enzymatic systems capable of producing reactive oxygen species (ROS) such as NADPH oxidase (NOX) and cyclooxygenase in vascular endothelial cells, NOX and cytochrome c oxidase in macrophages as well as nitric oxide synthase and lipoxygenase in platelets contributing to both early and late stages of atherosclerosis. P. gingivalis seems to be markedly involved in the atherosclerotic process as compared to A. actinomycetemcomitans contributing to LDL oxidation and foam cell formation. Particularly interesting is the evidence describing the NLRP3 inflammasome activation as a new molecular mechanism underlying P. gingivalis-induced oxidative stress and inflammation. Amongst viral agents, immunodeficiency virus-1 and hepatitis C virus seem to have a major role in promoting ROS production, contributing, hence, to the early stages of atherosclerosis including endothelial dysfunction and LDL oxidation. In conclusion, oxidative mechanisms activated by several infectious agents during the atherosclerotic process underlying CVDs are very complex and not well-known, remaining, thus, an attractive target for future research.<\/jats:p>","DOI":"10.3390\/ijms18112459","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T11:35:45Z","timestamp":1511177745000},"page":"2459","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress"],"prefix":"10.3390","volume":"18","author":[{"given":"Marisa","family":"Di Pietro","sequence":"first","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University, Piazzale Aldo Moro, 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-8588","authenticated-orcid":false,"given":"Simone","family":"Filardo","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University, Piazzale Aldo Moro, 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Falasca","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Sapienza University, Viale di Porta Tiburtina, 28, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Turriziani","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Sapienza University, Viale di Porta Tiburtina, 28, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sessa","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University, Piazzale Aldo Moro, 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,11,18]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2011). Global Status Report on Noncommunicable Diseases 2010, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4330\/wjc.v6.i6.462","article-title":"Antioxidants, inflammation and cardiovascular disease","volume":"6","author":"Mangge","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27770","DOI":"10.3390\/ijms161126059","article-title":"Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases","volume":"16","author":"He","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative Stress in Atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis","volume":"120","author":"Xia","year":"2017","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1074248413504994","article-title":"Inflammation and atherosclerosis\u2014Revisited","volume":"19","author":"Pant","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wu, M.Y., Li, C.J., Hou, M.F., and Chu, P.Y. (2017). New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102034"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1582-4934.2009.00978.x","article-title":"The vicious circle between oxidative stress and inflammation in atherosclerosis","volume":"14","author":"Hulsmans","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2016.12.004","article-title":"NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis","volume":"102","author":"Lozhkin","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37481","DOI":"10.1074\/jbc.M506412200","article-title":"Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production","volume":"280","author":"Korenaga","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1160\/TH11-06-0392","article-title":"Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis","volume":"106","author":"Rosenfeld","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2012.03.019","article-title":"HIV-1, reactive oxygen species, and vascular complications","volume":"53","author":"Porter","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15105","DOI":"10.3390\/ijms140715105","article-title":"Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: A brief overview","volume":"14","author":"Filardo","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_14","first-page":"595981","article-title":"Periodontal pathogens and atherosclerosis: Implications of inflammation and oxidative modification of LDL","volume":"2014","author":"Yamamoto","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/1354750X.2013.877967","article-title":"Presence of cytomegalovirus DNA in leucocytes is associated with increased oxidative stress and subclinical atherosclerosis in healthy adults","volume":"19","author":"Lee","year":"2014","journal-title":"Biomarkers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.12998\/wjcc.v2.i7.240","article-title":"Infectious burden and atherosclerosis: A clinical issue","volume":"16","author":"Sessa","year":"2014","journal-title":"World J. Clin. Cases"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"378658","DOI":"10.1155\/2015\/378658","article-title":"Chlamydia pneumoniae-mediated inflammation in atherosclerosis: A meta-analysis","volume":"2015","author":"Filardo","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2007.01917.x","article-title":"The periodontal pathogen Porphyromonas gingivalis cleaves apoB-100 and increases the expression of apoM in LDL in whole blood leading to cell proliferation","volume":"263","author":"Bengtsson","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/IAI.00777-10","article-title":"Lipoxin A4 inhibits Porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression","volume":"79","author":"Brodin","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3892\/or.2013.2600","article-title":"Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages","volume":"30","author":"Li","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0765.2009.01225.x","article-title":"Enhanced monocyte migration and pro-inflammatory cytokine production by Porphyromonas gingivalis infection","volume":"45","author":"Pollreisz","year":"2010","journal-title":"J. Periodontal Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bugueno, I.M., Khelif, Y., Seelam, N., Morand, D.N., Tenenbaum, H., Davideau, J.L., and Huck, O. (2016). Porphyromonas gingivalis differentially modulates cell death profile in ox-LDL and TNF-\u03b1 pre-treated endothelial cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154590"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yjmcc.2016.03.017","article-title":"Porphyromonas gingivalis, a periodontal pathogen, enhances myocardial vulnerability, thereby promoting post-infarct cardiac rupture","volume":"99","author":"Shiheido","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ftv011","DOI":"10.1093\/femspd\/ftv011","article-title":"Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis","volume":"73","author":"Yamaguchi","year":"2015","journal-title":"Pathog. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/039463200902200102","article-title":"Chlamydia pneumoniae and atherosclerosis: Current state and future prospectives","volume":"22","author":"Sessa","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_26","first-page":"367","article-title":"Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients","volume":"24","author":"Schiavoni","year":"2010","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.arcmed.2015.05.006","article-title":"Infection and Atherosclerosis Development","volume":"46","author":"Campbell","year":"2015","journal-title":"Arch. Med. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1067\/mva.2003.200","article-title":"Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease","volume":"37","author":"Sessa","year":"2003","journal-title":"J. Vasc. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/j.atherosclerosis.2007.04.052","article-title":"Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease","volume":"195","author":"Sessa","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00198-012-2217-1","article-title":"Chlamydia pneumoniae and osteoporosis-associated bone loss: A new risk factor?","volume":"24","author":"Schiavoni","year":"2013","journal-title":"Osteoporos. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/ijms16010724","article-title":"Chlamydia pneumoniae and oxidative stress in cardiovascular disease: State of the art and prevention strategies","volume":"16","author":"Filardo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12192-012-0378-7","article-title":"Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis","volume":"18","author":"Kreutmayer","year":"2013","journal-title":"Cell Stress Chaperones"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1440-1681.2011.05657.x","article-title":"Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species","volume":"39","author":"Rivera","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00430-004-0223-4","article-title":"Elicitation of reactive oxygen species in Chlamydia pneumoniae-stimulated macrophages: A Ca2+-dependent process involving simultaneous activation of NADPH oxidase and cytochrome oxidase genes","volume":"194","author":"Azenabor","year":"2005","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1160\/TH04-06-0360","article-title":"Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins","volume":"94","author":"Bylin","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fcimb.2015.00086","article-title":"Chlamydia pneumoniae clinical isolate from gingival crevicular fluid: A potential atherogenic strain","volume":"5","author":"Filardo","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fmicb.2016.01287","article-title":"Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment","volume":"7","author":"Evani","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_38","first-page":"1","article-title":"Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1","volume":"6","author":"Campbell","year":"2013","journal-title":"Pathog. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1194\/jlr.M300456-JLR200","article-title":"Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells","volume":"5","author":"Vielma","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/IAI.73.7.4315-4322.2005","article-title":"Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway","volume":"73","author":"Yaraei","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/498617","article-title":"Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis","volume":"193","author":"Nazzal","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2007.03.024","article-title":"Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors","volume":"566","author":"Andersson","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/01.CIR.0000031704.78200.59","article-title":"Cardiovascular Manifestations of HIV Infection","volume":"106","author":"Barbaro","year":"2002","journal-title":"Circulation"},{"key":"ref_44","first-page":"12","article-title":"Intact and altered endothelium in regulation of vasomotion","volume":"86","author":"Lerman","year":"1992","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0923-2516(06)80018-X","article-title":"Human endothelial cells isolated from the hepatic sinusoids and the umbilical vein display a different permissiveness for HIV1","volume":"144","author":"Lafon","year":"1993","journal-title":"Res. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: Relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"key":"ref_47","first-page":"163","article-title":"HIV-1 infection, microenvironment and endothelial cell dysfunction","volume":"39","author":"Mazzuca","year":"2016","journal-title":"New Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2459\/JCM.0b013e3283619331","article-title":"HIV-related mechanisms in atherosclerosis and cardiovascular diseases","volume":"14","author":"Gibellini","year":"2013","journal-title":"J. Cardiovasc. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2003.01543.x","article-title":"HIV-Tat protein induced oxidative and inflammatory pathways in brain endothelium","volume":"84","author":"Toborek","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/viro.2001.0998","article-title":"HIV Tat Activates c-Jun Amino-terminal Kinase through an Oxidant-Dependent Mechanism","volume":"286","author":"Gu","year":"2001","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2005.03.031","article-title":"HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells","volume":"1045","author":"Price","year":"2005","journal-title":"Brain Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.freeradbiomed.2010.02.023","article-title":"HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: Potential role of the thiol antioxidant N-acetylcysteine amide","volume":"8","author":"Banerjee","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"L252","DOI":"10.1152\/ajplung.00200.2004","article-title":"HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling","volume":"289","author":"Liu","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_54","first-page":"713","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in patients with HIV\/AIDS does not appear to correlate with cytomegalovirus retinitis","volume":"9","author":"Greenwood","year":"1998","journal-title":"Int. J. STD AIDS"},{"key":"ref_55","first-page":"359","article-title":"Antiretroviral molecules and cardiovascular diseases","volume":"35","author":"Gibellini","year":"2012","journal-title":"New Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C Virus Infection Is Associated with Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2009.10.005","article-title":"Hepatitis C virus RNA localization in human carotid plaques","volume":"47","author":"Boddi","year":"2010","journal-title":"J. Clin. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.25508","article-title":"Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations","volume":"55","author":"Petta","year":"2012","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Branche, E., Conzelmann, S., Parisot, C., Bedert, L., L\u00e9vy, P.L., Bartosch, B., Cl\u00e9ment, S., and Negro, F. (2016). Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146000"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/v5020439","article-title":"HCV and oxidative stress in the liver","volume":"5","author":"Ivanov","year":"2013","journal-title":"Viruses"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1742-1241.2004.00170.x","article-title":"Insulin resistance in chronic hepatitis C","volume":"58","author":"Yazicioglu","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hepres.2005.11.001","article-title":"Oxidative stress and hepatitis C viral infection","volume":"34","author":"Koike","year":"2006","journal-title":"Hepatol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcb.2003.11.001","article-title":"A trip to the ER: Coping with stress","volume":"14","author":"Rutkowski","year":"2004","journal-title":"Trends Cell Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1743-422X-10-251","article-title":"Oxidative stress and hepatitis C virus","volume":"10","author":"Paracha","year":"2013","journal-title":"Virol. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0168-8278(00)80080-X","article-title":"Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease","volume":"32","author":"Majano","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: Molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: A systematic review","volume":"312","author":"Kohli","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.cmi.2015.12.030","article-title":"Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents","volume":"22","author":"Pavone","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2131\/jts.39.909","article-title":"Herpes simplex virus 2 infects human endothelial ECV304 cells and induces cell apoptosis synergistically with ox-LDL","volume":"39","author":"Zhang","year":"2014","journal-title":"J. Toxicol. Sci."},{"key":"ref_71","first-page":"2630865","article-title":"Herpes Simplex Virus Type 1 and Type 2 Infection Increases Atherosclerosis Risk: Evidence Based on a Meta-Analysis","volume":"2016","author":"Wu","year":"2016","journal-title":"Biomed Res. Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/0882824041310531","article-title":"Herpes simplex virus 1 induced LOX-1 expression in an endothelial cell line, ECV 304","volume":"17","author":"Chirathaworn","year":"2004","journal-title":"Viral Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI113208","article-title":"Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis","volume":"80","author":"Hajjar","year":"1987","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1073\/pnas.87.18.7095","article-title":"Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression","volume":"87","author":"Key","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2013.08.020","article-title":"Seropositivity to herpes simplex virus type 2, but not type 1 is associated with premature cardiovascular diseases: A population-based cross-sectional study","volume":"231","author":"Mendy","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0049-3848(87)90241-6","article-title":"Induction of endothelial cell procoagulant activity by cytomegalovirus infection","volume":"47","author":"Bruggeman","year":"1987","journal-title":"Thromb. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.8023160","article-title":"Potential role of human cytomegalovirus and p53 interaction in coronary restenosis","volume":"265","author":"Speir","year":"1994","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocytes behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.CIR.0000109692.16004.AF","article-title":"Cytomegalovirus infection impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine in transplant arteriosclerosis","volume":"109","author":"Weis","year":"2004","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/2049-632X.12001","article-title":"Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis","volume":"67","author":"Cai","year":"2013","journal-title":"Pathog. Dis."},{"key":"ref_81","first-page":"509","article-title":"Resveratrol in Chlamydia pneumoniae induced foam cell formation and interleukin-17A sythesis","volume":"27","author":"Schiavoni","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bbrc.2004.10.155","article-title":"Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1)","volume":"325","author":"Dogne","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1556\/AMicr.57.2010.2.7","article-title":"Induced expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin","volume":"57","author":"Prochnau","year":"2010","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.femsim.2004.12.003","article-title":"Mechanisms of Porphyromonas gingivalis-induced monocyte chemoattractant protein-1 expression in endothelial cells","volume":"44","author":"Choi","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1021\/jf0351164","article-title":"Inhibitory actions of several natural products on proliferation of rat vascular smooth muscle cells induced by Hsp60 from Chlamydia pneumoniae J138","volume":"52","author":"Fukuoka","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ajcn\/83.4.870","article-title":"Vitamins C and E in adolescents and young adults with HIV infection","volume":"83","author":"Stephensen","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/00002030-199813000-00013","article-title":"Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects","volume":"12","author":"Allard","year":"1998","journal-title":"Aids"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H18","DOI":"10.1152\/ajpheart.00260.2010","article-title":"Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2","volume":"299","author":"Ungvari","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/ATVBAHA.109.193375","article-title":"Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state","volume":"29","author":"Zakkar","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_90","first-page":"220","article-title":"Hepatitis C: Epidemiology and review of complementary\/alternative medicine treatments","volume":"4","author":"Patrick","year":"1999","journal-title":"Altern. Med. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.mcg.0000174023.73472.29","article-title":"Treatment of chronic hepatitis C virus infection via antioxidants: Results of a phase I clinical trial","volume":"39","author":"Melhem","year":"2005","journal-title":"J. Clin. Gastroenterol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/11\/2459\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:50:13Z","timestamp":1760208613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/11\/2459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,18]]},"references-count":91,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"alternative-id":["ijms18112459"],"URL":"https:\/\/doi.org\/10.3390\/ijms18112459","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,18]]}}}